Journal of Surgical Oncology

• 

  Publication Venue For

  • Prognostic utility of albumin-bilirubin grade for short- and long-term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: A multi-institutional analysis of 706 patients..  120:206-213. 2019
  • The optimal number of lymph nodes to evaluate among patients undergoing surgery for gallbladder cancer: Correlating the number of nodes removed with survival in 6531 patients..  119:1099-1107. 2019
  • Laparoscopic synchronous resection of colorectal cancer and liver metastases: A systematic review..  119:30-39. 2019
  • Safety and oncologic outcomes of robotic liver resections: A systematic review..  117:1517-1530. 2018
  • Management, outcomes, and prognostic factors of ruptured hepatocellular carcinoma: A systematic review..  117:341-353. 2018
  • Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis..  116:643-650. 2017
  • Liver transplantation for unresectable colorectal liver metastases: A systematic review..  116:288-297. 2017
  • Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with peritoneal hepatocellular carcinoma..  110:786-790. 2014
  • Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades..  107:659-664. 2013
  • Resection of large hepatocellular carcinoma (≥10 cm): a unique western perspective..  107:111-117. 2013
  • Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer.  100:703-707. 2009
  • Non-ampullary duodenal adenocarcinoma: Factors important for relapse and survival (Journal of Surgical Oncology (2009) 100, 2, (144-148)).  100:434. 2009
  • Can surgeons improve survival in stage IV melanoma?.  97:462-468. 2008
  • The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma—with special reference to the serum levels of des-gamma-carboxy prothrombin.  95:235-240. 2007
  • Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935..  94:599-606. 2006
  • Total thyroidectomy for differentiated thyroid cancer..  94:701-707. 2006
  • The Kraske procedure: a critical analysis of a surgical approach for mid-rectal lesions..  94:194-202. 2006
  • Submucosal resection of giant gastric lipoma..  94:63-67. 2006
  • Expression of chymase-positive cells in gastric cancer and its correlation with the angiogenesis: Commentary.  93:42-43. 2006
  • Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab..  91:173-180. 2005
  • Mucosal melanoma..  86:187-188. 2004
  • Mitochondrial DNA alterations in thyroid cancer..  82:170-173. 2003
  • Heterotopic ossification in rectal cancer: Rare finding with a novel proposed mechanism..  82:132-136. 2003
  • Adjuvant chemotherapy for osteosarcoma may not increase survival after neoadjuvant chemotherapy and surgical resection..  78:162-170. 2001
  • FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume..  77:237-242. 2001
  • Recurrent ductal carcinoma in situ after total mastectomy..  71:182-185. 1999
  • MCA106 fibrosarcoma cells transduced with granulocyte/macrophage colony-stimulating factor are not superior to the wild-type cells in suppressing the growth of hepatic metastases..  71:36-45. 1999
  • Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice..  68:79-91. 1998
  • Prognostic value of MIB-1 in advanced ovarian carcinoma as determined using automated immunohistochemistry and quantitative image analysis..  66:230-236. 1997
  • Primary malignant melanoma of the esophagus..  66:201-206. 1997
  • Appendiceal carcinoma: patterns of failure following surgery and implications for adjuvant therapy..  66:51-53. 1997
  • Interlaboratory variation in oxygen tension measurement by Eppendorf "Histograph" and comparison with hypoxic marker..  66:30-38. 1997
  • Prognostic factors for fibromatoses: a correlation of proliferation index, estrogen receptor, p53, retinoblastoma, and src gene products and clinical features with outcome..  65:117-122. 1997
  • Intratumoral heterogeneity in primary breast carcinoma: study of concurrent parameters..  64:280-287. 1997
  • Long-term results of therapy for stage C neuroblastoma..  63:172-178. 1996
  • Correlation of DNA ploidy and histologic diagnosis from prostate core-needle biopsies: is DNA ploidy more sensitive than histology for the diagnosis of carcinoma in small specimens?.  63:41-45. 1996
  • Prognostic value of BHCG and local tumor invasion in stage I seminoma of the testis..  61:131-133. 1996
  • Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer..  60:122-127. 1995
  • Clinical outcome after neoadjuvant thermoradiotherapy in high grade soft tissue sarcomas..  57:143-151. 1994
  • Intraportal injection of monoclonal antibody in nude mice bearing hepatic metastases..  54:71-77. 1993
  • Flow cytometric DNA analysis of interleukin-2 responsive renal cell carcinoma..  53:252-255. 1993
  • A phase I/II study of intraoperative radiotherapy in advanced unresectable or recurrent carcinoma of the rectum: a Radiation Therapy Oncology Group (RTOG) study..  53:20-29. 1993
  • Substituting ornithine for arginine in total parenteral nutrition eliminates enhanced tumor growth..  50:161-167. 1992
  • Endobronchial interstitial Au-198 implantation in the treatment of recurrent bronchogenic carcinoma..  49:213-219. 1992
  • p53 alterations in all stages of breast cancer..  48:260-267. 1991
  • Proliferation index in various stages of breast cancer determined by Ki-67 immunostaining..  48:11-20. 1991
  • Colorectal ornithine decarboxylase activity in human mucosa and tumors: elevation of enzymatic activity in distal mucosa..  47:117-120. 1991
  • Acral melanoma: a review of 185 patients with identification of prognostic variables..  45:91-98. 1990
  • Effects of hyperthermia and irradiation on the growth of mouse melanoma tumors following immunotherapy..  44:256-259. 1990
  • Inhibition of the growth of human melanoma xenografts in nude mice by human tumor-specific cytotoxic T-cells..  43:67-72. 1990
  • Surgery in patients with unsuspected pheochromocytomas..  41:65-69. 1989
  • Stage II malignant melanoma: presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patients..  39:139-147. 1988
  • Biochemical and ultrastructural differences between muco-epidermoid and carcinoid tumors of the bronchus..  37:227-231. 1988
  • Plasma proteins as indices of response to nutritional therapy in cancer patients..  29:160-165. 1985
  • Immunodiagnosis of tumors in vivo using radiolabeled monoclonal antibody A2B5..  23:205-211. 1983
  • Human melanoma growth in the peritoneal cavity of the athymic mouse--a model for in vivo study of cell-mediated immunity..  17:309-320. 1981
  • In vivo evaluation of cell mediated immunity against human melanoma..  17:263-278. 1981
  • Influence of mouse hepatitis virus on the growth of human melanoma in the peritoneal cavity of the athymic mouse..  17:327-339. 1981
  • Characterization of melanoma cell membrane tumor-associated antigens using xenoserum, alloserum, and autoserum: I. immunofluorescence..  14:367-377. 1980
  • Non-specific and specific active immunotherapy in a B16 murine melanoma system..  12:87-96. 1979
  • Production and secretion of proteolytic enzymes by normal and neoplastic cells..  11:275-282. 1979
  • Establishment of a nude mouse model of hepatic metastasis for evaluation of targeted retroviral gene delivery: Commentary.  82:131. 2003
  • Patterns of recurrence of colorectal cancer. 2008